Market overview

4-FBA is a para-fluorinated aromatic aldehyde, a colourless liquid that brings a 4-fluorophenyl group into condensation and coupling reactions. Its best-known outlet is the diketone intermediate of atorvastatin, with further use in other APIs, pesticides and dyes. Supply depends on fluorobenzene or 4-fluorotoluene feedstock and is concentrated in China, with smaller output in India and Europe.

The question this report answers
How large is the 4-FBA market, how dependent is it on atorvastatin, and which suppliers can serve regulated pharma buyers to 2035?

1. Demand: who uses 4-FBA and where it is growing

Pharmaceutical intermediates, led by the atorvastatin diketone, are the largest use, and China and India are the largest consuming regions (Market Krystal estimate; Pfizer).

Demand by application (share of 2025 consumption, Market Krystal analysis)
– Pharmaceutical intermediates (atorvastatin and other APIs): 60%
– Pesticide intermediates: 20%
– Dye intermediates: 10%
– Other fine chemicals: 10%
QYResearch names pharmaceutical, dye and pesticide intermediates without shares; Market Krystal weights pharma highest because 4-FBA is the starting material of the atorvastatin diketone, and places demand where generic statin APIs are made.

Demand by region (share of 2025 consumption, Market Krystal analysis)
– China: 40%
– India: 30%
– Europe: 15%
– North America: 8%
– Rest of world: 7%

Where demand grows fastest to 2035
– Pharmaceutical intermediates: QYResearch expects the market to grow 4.6% a year to USD 38 mn in 2029, with pharma the lead segment (QYResearch)
– Pesticide intermediates: Pesticide use is expected to grow broadly in line with the market as new fluorinated actives are registered (QYResearch)

2. Supply: who makes 4-FBA and how much

QYResearch names Jiangsu Wanlong, Jiyuan Hengshun, WeylChem and Yingkou Xingfu among makers; Navin Fluorine lists 4-FBA in its catalogue (QYResearch; Navin Fluorine). No global capacity figure is published; Market Krystal places nameplate at 4,000-6,000 t/yr, mostly at Chinese plants named by QYResearch (Market Krystal estimate; QYResearch).

Main producers and capacity
– Navin Fluorine International (India): listed in its specialty fluorochemicals product range; capacity not published (Navin Fluorine product list)
– TCI (Tokyo Chemical Industry) (Japan): 98% grade in 25-250 mL packs; larger lots on request (TCI)
– Thermo Fisher Scientific (USA): 98% catalogue grade in 25-500 g packs

Production by region (share of 2025 output, Market Krystal analysis)
– China: 75%
– India: 15%
– Europe: 10%

Trade and supply-demand balance
China exports 4-FBA to Indian generic API makers and to Europe; India is a net importer that is adding domestic fluoroaromatic supply (Market Krystal estimate).

3. Value chain: from feedstock to end market

Fluorobenzene + 4-Fluorotoluene + Carbon monoxide, HCl and aluminium chloride → 4-FBA → Pharmaceutical intermediates (atorvastatin and other APIs), Pesticide intermediates, Dye intermediates

Raw materials
– Fluorobenzene: feed for direct formylation with CO and HCl; the main cost line (Market Krystal estimate)
– 4-Fluorotoluene: alternative feed through side-chain chlorination and hydrolysis (Market Krystal estimate)
– Carbon monoxide, HCl and aluminium chloride: formylation reagents; catalyst handling drives effluent cost (Market Krystal estimate)

Production route
Gattermann-Koch formylation of fluorobenzene with CO and HCl over aluminium chloride is the main route; side-chain chlorination of 4-fluorotoluene followed by hydrolysis, and Halex of 4-chlorobenzaldehyde, are alternatives.

Downstream
4-FBA reacts with 2-benzylidene isobutyryl acetanilide in a Stetter reaction to give the atorvastatin diketone (Pfizer), and is also used for pyrazolopyridine kinase inhibitors (Thermo Fisher Scientific) and as a feed for further fluorinated intermediates (Gujarat Fluorochemicals).

Price, cost and margin
Bulk prices are indicative at USD 8-11/kg; margin sits with producers that integrate fluorobenzene or 4-fluorotoluene and sell pharma grade. Bulk 4-FBA trades at an indicative USD 8-11/kg against about USD 1.50/g for 98% research packs (Thermo Fisher Scientific). Margin sits in pharma-grade purity and long-term supply to generic statin makers.

Where the chain is tightest
Fluorobenzene supply is the most exposed step, because Chinese fluorobenzene capacity is concentrated and subject to safety closures.

Who sits where in the chain
– Producer: Navin Fluorine International, WeylChem Group, Jiangsu Wanlong Chemical
– End user: Pfizer
– Converter: Gujarat Fluorochemicals
– Distributor: TCI, Thermo Fisher Scientific

4. Market size: what demand, supply and price add up to

Market Krystal preliminary estimate (2025)
QYResearch sizes 4-FBA at USD 29 mn in 2022, rising to USD 38 mn by 2029 at 4.6% a year. GlobalInfo Research and BAC Reports cover the molecule without public figures. QYResearch's growth path implies about USD 33 mn in 2025. Market Krystal checks this against 2,500-4,000 t of demand at an indicative bulk price of USD 8-11/kg and sets a USD 28-40 mn range. On this basis we use USD 28-40 mn. Confidence grade B: published estimates exist; the volume or price cross-check is partial.

How published estimates compare
QYResearch is the only publisher with a public 4-FBA value, at USD 29 mn for 2022. Market Krystal checks its growth path against demand volume and indicative bulk price and finds it consistent.

Key figures at a glance (third-party, cited)
– Global 4-FBA market of USD 29 mn in 2022, projected to reach USD 38 mn by 2029 at 4.6% a year (QYResearch)
– The atorvastatin diketone is made in a single step from 4-FBA and 2-benzylidene isobutyryl acetanilide (Pfizer)
– Research packs sell at USD 225 per 250 mL (TCI)
– WeylChem started Halex production in Frankfurt in 2021 for tens to several hundred tonnes of specialty fluoroaromatics a year (WeylChem via CHEManager)

5. Outlook to 2035 and scenarios to 2047

Regulation and substitution
Flammable liquid (H226) and irritant; substitution risk is low for established generics such as atorvastatin, whose commercial route is fixed in filed processes (TCI; Pfizer).

Recent developments among key stakeholders
– Aug 2026: CARE upgraded Navin Fluorine to AA+ as FY26 revenue rose about 41% to INR 3,314 crore; specialty chemicals were about 35% of sales (CARE Ratings)
– Sep 2025: Navin Fluorine's INR 540 crore Dahej fluoro-specialty plant was commissioned, with supplies starting in Q3 FY25 (CARE Ratings)
– Oct 2021: WeylChem, a named 4-FBA producer, started Halex production of specialty fluoroaromatics in Frankfurt-Fechenheim (WeylChem via CHEManager)

What this means for the market
4-FBA demand is tied to generic atorvastatin volumes, which are large but mature, so growth is steady rather than fast. Indian API makers depend on Chinese 4-FBA, which favours Indian fluorochemical producers such as Navin Fluorine that can offer local supply. European buyers have WeylChem as a regional option.

Strategic scenarios to 2047
– Base: Demand grows about 4% a year with generic statins and new APIs, and the market reaches USD 70-90 mn by 2047.
– Constrained supply: Chinese fluorobenzene closures lift 4-FBA prices 25-40% and accelerate Indian capacity.
– Technology transition: Biocatalytic or alternative atorvastatin routes reduce 4-FBA use per tonne of API.
The swing factor for 4-FBA is Generic atorvastatin volumes. Signposts: Atorvastatin API output in India and China, fluorobenzene price, Indian fluoroaromatic capex, new kinase inhibitor approvals using 4-fluorophenyl groups.

What this report delivers
Annual volume (tonnes) and value (USD) for 2026-2035, segmented by application: Pharmaceutical intermediates, Pesticide intermediates, Dye intermediates, Other fine chemicals; end use: Statins and other APIs, Crop protection actives, Dyes, Fine chemicals; region: China, India, Europe, North America, Rest of world. Each segment is backed by a producer capacity map, trade data and the Market Krystal estimate log, with scenarios to 2047 and strategic recommendations.